Adaptive Innovations, an AI-native home healthcare provider, has successfully closed a $50 million Series A funding round, co-led by Felicis and Bain Capital Ventures. This significant investment aims to scale the company's innovative model, which leverages artificial intelligence to drastically reduce administrative overhead in home health care, a sector plagued by an estimated $40 billion in rejected patient referrals annually. The funding round also saw participation from Optum Ventures, Sunflower Capital, Conviction, BoxGroup, and other investors, bringing Adaptive's total funding to $60 million including a previously unannounced seed round.
The company's core mission is to address a critical flaw in the American healthcare system where, as stated by investor Felicis, "Two in every five patients referred to home health in America never get the care they need." This issue arises not from a lack of clinicians or patient eligibility, but because the administrative costs associated with paperwork often exceed the reimbursement for a visit, leading agencies to turn patients away. Adaptive Innovations tackles this by using AI to manage intake, scheduling, prior authorization, documentation, and billing, processes that traditionally consume 60 to 90 cents of every clinical-labor dollar.
By collapsing these administrative costs, Adaptive Innovations makes it economically viable to serve patients who would otherwise be rejected, often ending up in nursing facilities or experiencing worsening conditions until emergency room intervention is required. Felicis highlighted the impact of this model, noting that "When those costs collapse, the patients who would have been rejected instead get the care that they deserve." This approach allows clinicians to spend significantly more time on patient care rather than administrative tasks.
Adaptive's model has demonstrated remarkable success in its initial market in Texas, where it has already delivered over 100,000 home health visits. Patients served by Adaptive exhibit a 4.9% rehospitalization rate, significantly lower than the 12.9% Texas state average and the 10.2% national average. Furthermore, over 95% of Adaptive's patients show improvement in ambulation, surpassing the national average of 89.5%, and 99% of patients are admitted within 48 hours of referral. The company also boasts a 4.5-star CMS quality rating, exceeding the industry average of approximately 3 stars, underscoring its commitment to high-quality, efficient care.
Co-CEOs Alex Wendland and Logan Stinson, alongside CTO Ryan Tolsma and COO Hunter Stinson, lead Adaptive Innovations, bringing a blend of AI expertise and deep clinical and operational experience in home health. The new capital will be used to expand Adaptive's operations nationwide, with plans to acquire small-cap home health businesses and scale its AI-driven model to more than a dozen states. This expansion aims to transform the home health landscape, ensuring more patients receive timely and effective care in the comfort of their homes.
